Skin News and Research

RSS

$20.7 million to make smallpox vaccine safer

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded a five-year, $20.7 million grant to National Jewish Medical and Research Center to lead a consortium of academic medical centers trying to make smallpox vaccines safer for millions of people with atopic dermatitis, also known as eczema.

19 May 2004

Damaged metal halide lamps can cause sunburn

Ever think you could get a nasty sunburn — severe enough to peel — by attending an indoor event? Seems improbable, but it can happen. And it has — three times recently in Middle Tennessee.

19 May 2004

$1.5 billion annual cost of surgical site infections can be reduced

A research paper published in the American Journal of Infection Control says a systematic approach to preparing patients for surgery can reduce both secondary, hospital-acquired patient infections and related healthcare expenses nationwide.

19 May 2004

Study comparing the efficacy of REMICADE® to Azathioprine alone and in combination With REMICADE®

Centocor, Inc., and Schering-Plough Corporation announced today the initiation of the SONIC (Study of Immunomodulator Naive patients in Crohn's Disease) trial that will evaluate the efficacy of REMICADE® (infliximab) versus azathioprine, a conventional immunosuppressive agent, alone and versus the combination of both drugs for the treatment of patients with Crohn's disease.

18 May 2004

Interventional radiologists now are able to treat using minimally invasive procedures

Interventional radiologists at Temple University Hospital now are able to treat many patients with minimally invasive procedures not available only a few years ago. “Conditions that used to require extensive surgery now take an hour or less, and patients leave with a bandaid and walk home,” says Gary Cohen, M.D., Section Chief of Interventional Radiology and Vice Chairman of Radiology. “How can you beat that?”

17 May 2004

Connetics issued U.S. patent for emollient-foam technology

Connetics Corporation, a specialty pharmaceutical company that develops and commercializes dermatology products, announced today that on May 4, 2004 the United States Patent and Trademark Office (USPTO) issued to Connetics Patent No. 6,730,288 B1. The patent has 7 independent product claims, and covers a pharmaceutical aerosol foam composition having occlusive capability.

17 May 2004

Researchers demonstrate wearable electronics to aid health and fashion

Soon you may be wearing your computer, or elements of it, according to a team of researchers and designers at Arizona State University. The era of smart bodysuits is about to begin.

17 May 2004

Five million village doctors in rural China to be re-trained

A memorandum which is to lead to the re-training of five million village doctors in rural China is to be signed on 23 May in Beijing, China. The memorandum goes back to the initiative of Terence Ryan, Professor of Dermatology at the University of Oxford, who has been instrumental in drawing it up and will participate in the signing.

14 May 2004

Study of hematopoietic stem cell transplantation for severe, treatment-resistant lupus

The study will include a basic research component to examine the roles of B and T cells, white blood cells in the immune system, in triggering lupus symptoms.

14 May 2004

Expert panel to review toxicity associated with exposure to acrylamide

The National Institute of Environmental Health Sciences (NIEHS), one of the National Institutes of Health (NIH), will hold an expert panel meeting May 17-19, in Alexandria, Virginia, to review the scientific evidence regarding the potential reproductive and/or developmental toxicity associated with exposure to acrylamide.

10 May 2004

Bone marrow and stem cell transplantation rejection averted by UV light exposure

One of the unfortunate side effects of bone marrow and stem cell transplantation is that the newly implanted cells often stage an internal attack against the patient they're intended to help.

10 May 2004

Soybeans may reduce the risk of colon cancer

A substance found in soybeans may reduce the risk of colon cancer, the third most common form of cancer in the world according to the World Health Organization.

10 May 2004

Alternative vaccine to Dryvax for smallpox

Not everybody can safely be vaccinated against smallpox using the current FDA-approved vaccine. Scientists hope another study vaccine, now undergoing its first testing in the United States at Saint Louis University, will give a choice to people who can't be given the current vaccine, known as Dryvax®.

10 May 2004

British parents ignore skin cancer warnings

Over a third of parents in Great Britain admit their child has been sunburnt, despite the majority knowing that over-exposure to the sun can cause skin cancer.

9 May 2004

Discovery of immune system malfunction that plays a profound role in food allergy

A team of scientists, led by the Institute of Food Research (IFR) in the UK, has discovered an immune system malfunction that is likely to play a profound role in food allergy.

8 May 2004

Traditional Chinese medicine contains human placenta

MHRA (Medicines) has recently become aware of a traditional Chinese medicine called Nu Bao. The product patient information leaflet lists human placenta (Placenta hominis), deer antler (Corna cervi pantotrichum) and donkey skin (Colla cori astini) as ingredients.

8 May 2004

Study has found the Sars virus in sweat glands and the intestine

Pathologists from the First Military Medical University in Guangzhou, southern China, warn that if further research proves that Sars can be transmitted by these unexpected routes, the implications for public health are major.

7 May 2004

Kodak forms JV with NZ researchers for world’s first non-invasive digital imaging breast screening technique

The multi-national Eastman Kodak Company is forming a joint venture company with researchers at the University of Canterbury, to develop the world’s first non-invasive digital imaging breast screening technique.

6 May 2004

A second-generation targetted antibody for potential cancer therapy

The overproduction, or 'overexpression', of the epidermal growth factor receptor (EGFR) is one of the most common aberrations in cancer, and subsequently agents that inhibit EGFR are among the most hotly-pursued potential products in the pharmaceutical industry.

6 May 2004

FDA approval of Hylaform and Restylane, both injectable gels, to treat facial wrinkles

The list of cosmetic soft tissue fillers on the market and in the pipeline worldwide is growing rapidly. Many have been introduced with great fanfare; relatively few stand the test of regulatory or peer review - as well as the test of time.

6 May 2004